Climb Bio, Inc. (CLYM)
10.36
-0.51
(-4.69%)
USD |
NASDAQ |
Nov 13, 16:00
10.35
-0.01
(-0.10%)
Pre-Market: 08:33
Climb Bio Price : 10.36 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 10.76 | 10.99 | 10.18 | 10.36 | 667835.0 |
| Nov 12, 2026 | 11.97 | 12.16 | 10.67 | 10.87 | 1.346M |
| Nov 11, 2026 | 11.72 | 12.44 | 11.49 | 12.25 | 1.664M |
| Nov 10, 2026 | 10.96 | 11.87 | 10.62 | 11.74 | 1.568M |
| Nov 09, 2026 | 10.49 | 11.54 | 10.28 | 11.01 | 1.784M |
| Nov 06, 2026 | 9.05 | 10.33 | 8.84 | 10.29 | 1.140M |
| Nov 05, 2026 | 8.87 | 9.20 | 8.485 | 8.87 | 1.435M |
| Nov 04, 2026 | 9.97 | 10.10 | 9.191 | 9.33 | 1.044M |
| Nov 03, 2026 | 9.86 | 10.07 | 9.56 | 9.75 | 887671.0 |
| Nov 02, 2026 | 10.25 | 10.44 | 9.69 | 9.74 | 1.147M |
| Oct 30, 2026 | 10.15 | 10.51 | 10.02 | 10.25 | 708754.0 |
| Oct 29, 2026 | 10.36 | 10.55 | 10.09 | 10.33 | 688983.0 |
| Oct 28, 2026 | 9.32 | 10.13 | 9.25 | 10.12 | 945761.0 |
| Oct 27, 2026 | 9.09 | 10.15 | 8.815 | 9.57 | 3.904M |
| Oct 26, 2026 | 9.88 | 9.99 | 8.70 | 8.81 | 3.381M |
| Oct 23, 2026 | 10.47 | 10.66 | 10.05 | 10.19 | 495694.0 |
| Oct 22, 2026 | 10.57 | 11.23 | 10.44 | 10.54 | 654057.0 |
| Oct 21, 2026 | 10.83 | 11.26 | 10.60 | 10.87 | 930386.0 |
| Oct 20, 2026 | 9.84 | 10.99 | 9.84 | 10.80 | 1.369M |
| Oct 19, 2026 | 9.92 | 10.43 | 9.61 | 9.73 | 1.214M |
| Oct 16, 2026 | 10.89 | 10.91 | 9.690 | 9.82 | 990428.0 |
| Oct 15, 2026 | 10.32 | 10.98 | 10.25 | 10.91 | 515488.0 |
| Oct 14, 2026 | 10.19 | 10.64 | 10.09 | 10.29 | 987717.0 |
| Oct 13, 2026 | 10.75 | 10.79 | 10.18 | 10.31 | 901344.0 |
| Oct 12, 2026 | 10.91 | 11.15 | 10.72 | 10.83 | 911847.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Korsana Biosciences, Inc. | 31.65 |
| Cullinan Therapeutics, Inc. | 10.28 |
| Q32 Bio, Inc. | 8.71 |
| Oncolytics Biotech, Inc. | 0.37 |
| Sangamo Therapeutics, Inc. | 0.117 |
Price Related Metrics
| PEG Ratio | -1.360 |
| Price to Book Value | 2.622 |
| Earnings Yield | -7.92% |
| Market Cap | 598.06M |
| PEGY Ratio | -1.360 |